Clinical Trial Update: Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting efficacy and safety results for S95011 in patients with Primary Sjögren's Syndrome; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• S95011

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Primary Sjögren's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2024-04-23